{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:11:33Z","timestamp":1778177493126,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Oncology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/s1470-2045(05)01737-7","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T07:34:00Z","timestamp":1107243240000},"page":"112-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":353,"title":["Theragnostic imaging for radiation oncology: dose-painting by numbers"],"prefix":"10.1016","volume":"6","author":[{"given":"S\u00f8ren M","family":"Bentzen","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1470-2045(05)01737-7_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/radiology.212.3.r99se18609","article-title":"Molecular imaging: exploring the next frontier","volume":"212","author":"Weissleder","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/S1470-2045(05)01737-7_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1126\/science.1090585","article-title":"Molecular imaging: looking at problems, seeing solutions","volume":"302","author":"Herschman","year":"2003","journal-title":"Science"},{"key":"10.1016\/S1470-2045(05)01737-7_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0360-3016(01)01749-7","article-title":"Intensity-modulated radiotherapy: current status and issues of interest","volume":"51","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2003.09.057","article-title":"High-tech in radiation oncology: should there be a ceiling?","volume":"58","author":"Bentzen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0730-725X(99)00006-5","article-title":"In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology","volume":"17","author":"Garcia-Segura","year":"1999","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/S1470-2045(05)01737-7_bib6","first-page":"249","article-title":"Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging","volume":"6","author":"Zelefsky","year":"2000","journal-title":"Cancer J"},{"key":"10.1016\/S1470-2045(05)01737-7_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.2002.20.2.379","article-title":"Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography","volume":"20","author":"Bos","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(00)00223-1","article-title":"A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy","volume":"57","author":"Nordsmark","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia: a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S1470-2045(05)01737-7_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0360-3016(02)04215-3","article-title":"Molecular (functional) imaging for radiotherapy applications: an RTOG symposium","volume":"55","author":"Chapman","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/crad.2001.0762","article-title":"Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies","volume":"56","author":"Padhani","year":"2001","journal-title":"Clin Radiol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jmri.1166","article-title":"BOLD MRI of human tumor oxygenation during carbogen breathing","volume":"14","author":"Taylor","year":"2001","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/S1470-2045(05)01737-7_bib13","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1158\/0008-5472.CAN-04-0842","article-title":"Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice","volume":"64","author":"Serganova","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(05)01737-7_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0959-8049(02)00838-9","article-title":"Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology","volume":"39","author":"Bernier","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/S1470-2045(05)01737-7_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S1470-2045(05)01737-7_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/09553000310001597002","article-title":"Repopulation in radiation oncology: perspectives of clinical research","volume":"79","author":"Bentzen","year":"2003","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0360-3016(02)04122-6","article-title":"Nuclear medicine imaging to predict response to radiotherapy: a review","volume":"55","author":"Van de Wiele","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S1470-2045(05)01737-7_bib19","first-page":"3331","article-title":"3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules","volume":"62","author":"Buck","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(05)01737-7_bib20","first-page":"3315","article-title":"In vivo validation of 3'deoxy-3'-[(18)F]-fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors","volume":"8","author":"Vesselle","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1470-2045(05)01737-7_bib21","first-page":"1688","article-title":"Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers","volume":"43","author":"Lu","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/S1470-2045(05)01737-7_bib22","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(05)01737-7_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2003.09.043","article-title":"The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck","volume":"58","author":"Eriksen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib24","first-page":"768","article-title":"99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin, part III: clinical trials safety and diagnostic efficacy","volume":"40","author":"Ramos-Suzarte","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/S1470-2045(05)01737-7_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nucmedbio.2003.12.005","article-title":"Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors","volume":"31","author":"Mishani","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jnci\/83.2.97","article-title":"Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma","volume":"83","author":"Divgi","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(05)01737-7_bib27","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1158\/1078-0432.CCR-03-0248","article-title":"Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy","volume":"10","author":"Buffa","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1470-2045(05)01737-7_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0167-8140(02)00075-0","article-title":"Optimizing radiation treatment plans for lung cancer using lung perfusion information","volume":"63","author":"Seppenwoolde","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(00)00467-3","article-title":"Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality","volume":"47","author":"Ling","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0360-3016(00)01433-4","article-title":"A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib31","series-title":"Basic clinical radiobiology","first-page":"134","article-title":"The linear-quadratic model in clinical practice","author":"Bentzen","year":"2002"},{"key":"10.1016\/S1470-2045(05)01737-7_bib32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0360-3016(03)01621-3","article-title":"Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer","volume":"58","author":"Parker","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib33","doi-asserted-by":"crossref","first-page":"N31","DOI":"10.1088\/0031-9155\/48\/2\/404","article-title":"On biologically conformal boost dose optimization","volume":"48","author":"Alber","year":"2003","journal-title":"Phys Med Biol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/srao.2002.33700","article-title":"Quality assurance of intensity-modulated radiotherapy","volume":"12","author":"Low","year":"2002","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1259\/bjr\/19737738","article-title":"Implementation of IMRT in the radiotherapy department","volume":"76","author":"McNair","year":"2003","journal-title":"Br J Radiol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.radonc.2004.02.016","article-title":"Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer","volume":"71","author":"Boehmer","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/S1470-2045(05)01737-7_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0360-3016(86)90153-7","article-title":"Acute hypoxia in tumors: implications for modifiers of radiation effects","volume":"12","author":"Chaplin","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(05)01737-7_bib39","first-page":"S247","article-title":"Microvascular studies on the origins of perfusion-limited hypoxia","volume":"27","author":"Dewhirst","year":"1996","journal-title":"Br J Cancer Suppl"}],"container-title":["The Lancet Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204505017377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204505017377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:52:18Z","timestamp":1761457938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204505017377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1470204505017377"],"URL":"https:\/\/doi.org\/10.1016\/s1470-2045(05)01737-7","relation":{},"ISSN":["1470-2045"],"issn-type":[{"value":"1470-2045","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Theragnostic imaging for radiation oncology: dose-painting by numbers","name":"articletitle","label":"Article Title"},{"value":"The Lancet Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(05)01737-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(05)01718-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}